U.S. Food and Drug Administration Product Analyst Salaries in Wilmington, DE
The average U.S. Food and Drug Administration Product Analyst in Wilmington, DE earns an estimated $100,042 annually, which includes an estimated base salary of $93,375 with a $6,667 bonus. U.S. Food and Drug Administration's Product Analyst compensation is $14,952 less than the US average for a Product Analyst. Product Analyst salaries at U.S. Food and Drug Administration in Wilmington, DE can range from $55,000 - $135,000.
In Wilmington, DE, The Product Department at U.S. Food and Drug Administration earns $41,038 more on average than the Legal Department.
Last updated 3 years ago.
- $93,375
- avg. base
- $6,667
- avg. bonus
Product Analyst Salaries at U.S. Food and Drug Administration
In Wilmington, DE, Product Analysts earn $2,775 more than Product Managers, and $18,089 less than Senior Product Managers.
Compensation at U.S. Food and Drug Administration by Department
In Wilmington, DE, The Product Department averages $41,038 more than the Legal Department, and $5,849 less than the Enterprise Risk Department
Product Analyst Compensation by Gender (All Companies)
The average female Product Analyst at companies similar size to U.S. Food and Drug Administration reported making $131,454, while the average male Product Analyst at similar sized companies reported making $138,128.
Product Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Product Analyst at companies similar size to U.S. Food and Drug Administration reported making $141,695, while the average African American/Black Product Analyst at similar sized companies reported making $108,963.
How Product Analysts at U.S. Food and Drug Administration Rate Their Compensation
The majority of Product Analysts at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Product Analysts at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
